AG Paxton Sues Big Pharma for 1,000% Insulin Price Hike Conspiracy

Translate to Spanish or other 102 languages!

 Texas Attorney General Ken Paxton sued major insulin manufacturers and pharmacy benefit managers (“PBMs”)—including Eli Lilly, Express Scripts, CVS Pharmacy, and others—over a conspiracy to increase prices of insulin. Image for illustration purposes
 Texas Attorney General Ken Paxton sued major insulin manufacturers and pharmacy benefit managers (“PBMs”)—including Eli Lilly, Express Scripts, CVS Pharmacy, and others—over a conspiracy to increase prices of insulin. Image for illustration purposes
- Advertisement -

AUSTIN – Texas Attorney General Ken Paxton sued major insulin manufacturers and pharmacy benefit managers (“PBMs”)—including Eli Lilly, Express Scripts, CVS Pharmacy, and others—over a conspiracy to increase prices of insulin.

Through this conspiracy, the manufacturers artificially and willingly raised the prices of insulin then paid a significant, undisclosed portion back to the PBMs as a quid pro quo for inclusion in the PBMs’ standard offerings. The PBMs then granted preferred status to the manufacturer whose drug has the highest list price while excluding lower priced drugs. These synthetic insulin drugs, which today cost the manufacturers less than $2 to produce and were originally priced at $20 when released in the late 1990s, now range between $300 and $700. In the last decade alone, the manufacturers who are defendants in the lawsuit have increased the prices of their insulins up to 1,000%. Attorney General Paxton is suing because the insulin pricing scheme violates the Texas Deceptive Trade Practices Act, constitutes unjust enrichment, and represents an unlawful civil conspiracy.

“This is a disturbing conspiracy by which pharmaceutical companies were intentionally and artificially inflating the price of insulin. Big Pharma insulin manufacturers and PBMs worked together to take advantage of diabetes patients and drive prices as high as they could,” said Attorney General Paxton. “These companies acted illegally and unethically to enrich themselves, and we will hold them accountable.”

- Advertisement -

According to the complaint, “While the PBM Defendants represent that they perform their services on behalf of their clients (including Texas payors) and diabetics to lower drug prices, increase access to affordable drugs, and promote diabetic health, these representations are false. Rather, the PBM Defendants have worked in coordination with the Manufacturer Defendants to distort the market for diabetic treatments to their benefit at the expense of Texas diabetics and payors.”

Liston & Deas, David Nutt & Associates, the Cicala Law Firm, and Foreman Watkins Krutz are serving as outside counsel.

To read the filing, click here.

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

16 Million at Risk for Skin Cancer Due to Growing Online Myths

Mega Doctor News by American Academy of Dermatology Newswise — ROSEMONT, Ill.-  The American Academy of Dermatology (AAD)...

STHS Takes Aim at Breast Cancer with New ‘Cinco de Mammo’ Campaign

To officially kick off this year’s initiative and commemorate Cinco de Mayo, STHS hosted a special luncheon on Tuesday, May 5, 2026, a gathering rooted in compassion, courage and unity. 

Texas Rural Health Gets $56M Lifeline for Prevention and Wellness Programs

Governor Greg Abbott announced the Texas Health and Human Services Commission (HHSC) will award $56 million in federal funding to rural hospitals advancing prevention, wellness, and nutrition programs in their communities.

Op Ed: Mental Health Can’t Wait: Break the Silence, Ignite Change 

May is Mental Health Awareness Month, a national observance that has been recognized since 1949, but its message has never been more urgent. In the United States, nearly 1 in 5 adults is living with a mental health condition, and more than 1 in 20 experience a serious mental illness that significantly interferes with daily life.
- Advertisement -